BBlogFlow

Technologies to measure and modulate protein subcellular localization - Nature

·Mar 19, 2026

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

This article is an excerpt. To read the full content, visit the original source. Nature

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

CTE Technology Advertising Co Ltd expands into the Mexican market, driving the localization of AI services. - markets.businessinsider.com

CTE Technology Advertising Co Ltd is expanding its AI data services in Mexico, focusing on AI model training, data annotation, content evaluation, application testing, local operations, and talent development to strengthen its capabilities in Mexico and Spanish-speaking markets. Denver, CO, Colorado, United States, October 7, 2026 -- CTE Technology Advertising Co Ltd (hereinafter referred to as "CTE") is a technology enterprise engaged in the research, development, and application of artificial intelligence technology; it is currently expanding its AI data service business in Mexico and strengthening its local operational capabilities. Currently, CTE's operations in Mexico primarily encompass AI model training, data annotation, content evaluation, and intelligent application testing, supporting the training and optimization of AI models through data processing, evaluation, and feedback. As part of its business development in Mexico, CTE is strengthening local operations and talent training to familiarize personnel with relevant workflows, task requirements, and quality standards, while progressively enhancing their digital work capabilities.

markets.businessinsider.com·

Combination nucleic acid therapies: towards personalized cancer treatment - Advanced Science News

Combination strategies enable simultaneous activation and silencing of key target genes to correct molecular pathways in pancreatic cancer. For the first time, scientists have designed combination therapies of small nucleic acid therapeutics based on the specific molecular characteristics of a tumor. These novel therapies work in an opposite but complementary way to regulate gene expression. This innovative approach, tested in pre-clinical models of pancreatic ductal adenocarcinoma (PDAC), shows superior anti-cancer effects compared to single nucleic acid therapies, offering the potential of flexible, precise, and personalized cancer treatments.

Advanced Science News·

ConnectWise Cloud Backup Supply-Chain Attack: Analysis of Microsoft 365 Tenant Compromise and Mitigation Strategies - Rescana

Executive SummaryOn October 15, 2026, unauthorized access to application identities within the ConnectWise Cloud Backup (formerly SkyKick Cloud Backup) environment enabled attackers to compromise at least 162 Microsoft 365 tenants. The breach was executed via a supply-chain attack, leveraging a stolen application credential to authenticate as a trusted service principal in customer environments. This allowed the attacker to inherit all permissions previously granted to the application, including broad access to emails, files, and directory data. The attack was confirmed by multiple independent sources, including Microsoft, Huntress, and ConnectWise. The incident led to the suspension of ConnectWise Cloud Backup and related services, with ongoing investigations and remediation efforts. There is currently no evidence that backup archives were accessed or exfiltrated, but the full scope of tenant impact remains under review. The attack bypassed multi-factor authentication (MFA) due to its use of application credentials rather than user logins.

Rescana·

The Verge switches up its audience team to prepare for Google Zero - Digiday

The Verge is rethinking what it means to grow an audience in the post-search era. After years of prioritizing SEO, content distribution, virality and referral traffic, the Vox Media-owned tech publisher has reorganized its audience team around turning casual site visitors into loyal, direct readers.

Digiday·